Harald F Krug

发表

From in vivo to in vitro: The medical device testing paradigm shift.

Thomas Hartung, Dayna Kerecman Myers, Alan M Goldberg, 2017, ALTEX.

Nanotoxicology: an interdisciplinary challenge.

Peter Wick, Harald F Krug, H. Krug, 2011, Angewandte Chemie.

Use of Cause-and-Effect Analysis to Design a High-Quality Nanocytotoxicology Assay.

Matthias Rösslein, Peter Wick, Marc Salit, 2015, Chemical research in toxicology.

Toward the development of decision supporting tools that can be used for safe production and use of nanomaterials.

Peter Wick, Bernd Nowack, Claudia Som, 2013, Accounts of chemical research.

Addition of nanoscaled bioinspired surface features: A revolution for bone related implants and scaffolds?

Peter Wick, Arie Bruinink, Harald F Krug, 2014, Journal of biomedical materials research. Part A.

Environmental Impacts of Engineered Nanomaterials—Imbalances in the Safety Assessment of Selected Nanomaterials

Dana Kühnel, Harald F Krug, Anita Jemec Kokalj, 2018, Materials.

Nanosafety research--are we on the right track?

Harald F Krug, H. Krug, 2014, Angewandte Chemie.

Evidence Maps: Communicating Risk Assessments in Societal Controversies: The Case of Engineered Nanoparticles

Harald F Krug, Holger Schütz, Albena Spangenberg, 2011, Risk analysis : an official publication of the Society for Risk Analysis.

Classification framework for graphene-based materials.

Bengt Fadeel, Peter Wick, Maurizio Prato, 2014, Angewandte Chemie.

The DaNa2.0 Knowledge Base Nanomaterials—An Important Measure Accompanying Nanomaterials Development

Dana Kühnel, Katja Nau, Harald F Krug, 2018, Nanomaterials.

120 years of nanosilver history: implications for policy makers.

Bernd Nowack, Harald F Krug, Murray Height, 2011, Environmental science & technology.

In vitro mechanistic study towards a better understanding of ZnO nanoparticle toxicity

Sanjay Mathur, Peter Wick, Cordula Hirsch, 2013, Nanotoxicology.

Biological effects of ultrafine model particles in human macrophages and epithelial cells in mono- and co-culture.

Harald F Krug, Silvia Diabaté, Ralf Wottrich, 2004, International journal of hygiene and environmental health.

Determination of the transport rate of xenobiotics and nanomaterials across the placenta using the ex vivo human placental perfusion model.

Peter Wick, Harald F Krug, H. Krug, 2013, Journal of visualized experiments : JoVE.

The adsorption of biomolecules to multi-walled carbon nanotubes is influenced by both pulmonary surfactant lipids and surface chemistry

Peter Wick, Harald F Krug, Michael Gasser, 2010, Journal of nanobiotechnology.

Nanoparticulate vanadium oxide potentiated vanadium toxicity in human lung cells.

Harald F Krug, H. Krug, J. M. Wörle-Knirsch, 2007, Environmental science & technology.

Effects of carbon nanotubes on primary neurons and glial cells.

Peter Wick, Cordula Hirsch, Harald F Krug, 2009, Neurotoxicology.

A comparison of acute and long-term effects of industrial multiwalled carbon nanotubes on human lung and immune cells in vitro.

Peter Wick, Harald F Krug, Barbara Rothen-Rutishauser, 2011, Toxicology letters.

Pulmonary surfactant coating of multi-walled carbon nanotubes (MWCNTs) influences their oxidative and pro-inflammatory potential in vitro

Peter Wick, Harald F Krug, Michael Gasser, 2012, Particle and Fibre Toxicology.

Toward achieving harmonization in a nano-cytotoxicity assay measurement through an interlaboratory comparison study.

John T Elliott, Blaza Toman, Peter Wick, 2016, ALTEX.

Nanomaterial cell interactions: how do carbon nanotubes affect cell physiology?

Peter Wick, Harald F Krug, H. Krug, 2009, Nanomedicine.

Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology.

Sangeeta Khare, Carsten Kneuer, Uwe Marx, 2015, ALTEX.